• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Lorlatinib’s Unique Challenges: Managing Cognitive and Metabolic AEs

Opinion
Video

Panelists discuss how lorlatinib’s unique adverse event (AE) profile, including cognitive effects, hypercholesterolemia, and peripheral neuropathy, impacts treatment selection and patient management.

Lorlatinib’s Unique Adverse Event Profile

Key Themes:

  • Cognitive effects, hypercholesterolemia, and peripheral neuropathy with lorlatinib
  • Impact of adverse events on treatment selection
  • Monitoring and management of cholesterol levels

Notable Insights:

  • Dr Dietrich discussed lorlatinib’s unique adverse event profile and its impact on treatment decisions

Dr Lovly outlined best practices for monitoring and managing lorlatinib-induced hypercholesterolemia

Related Videos
5 experts in this video
4 experts are featured in this series.
4 experts are featured in this series.
1 expert in this video
Dr Gerard Criner
Dr Margrit Wiesendanger
4 experts are featured in this series.
4 experts are featured in this series.
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.